NetBio

Formerly known as NetBio, the firm is now the first to gain approval under the new standards of the Rapid DNA Act of 2017.

Peter Vallone

Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages.

Title: Unitary biochip providing sample-in to results-out processing and methods of manufacture.
Patent Number: 8,720,036
Filed: Sept. 8, 2011

GE Healthcare Life Sciences and NetBio this week named several laboratories participating in a comprehensive developmental validation of the DNAscan Rapid DNA Analysis System.

Bioneer has been awarded US Patent No, 8,427,643, "Real-time PCR monitoring apparatus."
Hanee Park, Il Kyu Choi, and Han Oh Park are named as inventors.

Life Technologies said this week that it has become the exclusive worldwide distributor for LGC Forensics' recently launched ParaDNA platform, a portable DNA testing system designed to determine the quality of human DNA more quickly and efficiently than existing methods.

Scientists from Network Biosystems have published research demonstrating that the company's rapid, point-of-care system for diagnosing and differentiating Chlamydia trachomatis strains achieved greater sensitivity and specificity than a commercially available PCR-based

This article has been updated from a previous version to provide information regarding the name of ZyGem's DNA testing platform.

GE Healthcare and Network Biosystems this week announced a collaboration to commercialize rapid DNA analysis products for forensic applications.

NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and NetBio said on Monday they will commercialize new products for DNA sample collection and analysis for the forensics market.

Pages

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.